| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |